WILMINGTON, Del., July 1, 2024
/PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a
full-service, boutique global CRO, is excited to announce its
latest strategic move with the successful acquisition of
DeltaMed Solutions, an emerging CRO with a robust foothold in
the US. The acquisition, advised by Evercore as financial advisor,
marks HiRO's third CRO acquisition since its establishment in
2020.
Following the acquisitions of ANZ-based PharmaSols in 2021 and
US-based Courante Oncology last year, HiRO's global expansion
continues with the integration of DeltaMed Solutions. With its
established footprint in the US, Ireland,
Mainland China, Taiwan,
Australia, New Zealand, Japan, South
Korea, Malaysia, and
the Philippines, HiRO solidifies
its position as a comprehensive provider of end-to-end clinical
research solutions on a global scale.
DeltaMed Solutions, headquartered in New Jersey, boasts a team of highly skilled
industry professionals with 15-30 years of expertise in
serving large to mid-sized pharmaceutical and biotechs. The
leadership team also brings a wealth of experience in FDA and
EMEA submissions. DeltaMed Solutions is widely recognized for
its extensive experience and flexible service models in data
management, biostatistics, programming, RWE solutions, PK/PD
analysis, regulatory and medical affairs. The company has
earned recognition from clients and partners for its outstanding
track record of excellence and service quality.
The full integration of DeltaMed Solutions into HiRO's
operations will foster a powerful alliance, leveraging the
expertise of both companies in key therapeutic areas and service
offerings. This broadens HiRO's network of clients and partners,
and enhances its ability to deliver capital-efficient, expedited,
and customized clinical trial solutions, addressing the unmet
R&D needs of pharmaceutical and biotech companies
worldwide.
Dr. Karen Chu, Founder and CEO of HiRO, expressed her
confidence in the acquisition, stating, "We are delighted to
extend a warm welcome to DeltaMed Solutions. This acquisition
aligns seamlessly with HiRO's growth strategy, enhancing our
capability to continue delivering exceptional services that exceed
industry standards. By combining our resources and expertise, we
are strongly positioned to become our clients' trusted partner in
advancing patient treatments and making a lasting impact on the
healthcare landscape. This collaboration leverages our collective
strengths, ensuring optimal efficiency and effectiveness in
conducting clinical trials across a wide range of therapeutic areas
in the US, Asia-Pacific, and
beyond. This sets us apart as a pioneering force in the highly
competitive CRO industry."
Dr. Sam Liang, President of DeltaMed Solutions, added, "We
are thrilled to become an integral part of HiRO and contribute to
their continued success. This opportunity allows us to harness our
scientific expertise and well-established presence in the US.
Working together, we will offer an enriched, globally integrated
suite of services to our clients, driven by our shared dedication
to quality, innovation, and patient-centric research. This
collaboration will streamline processes and accelerate the
development of groundbreaking treatments."
With this strategic acquisition, HiRO and DeltaMed
Solutions join forces to provide an unparalleled range of services,
delivering bespoke and efficient clinical trial solutions that
effectively navigate market-specific complexities globally. Their
shared vision and commitment to excellence in clinical research
uniquely position them as key contributors to advancements in
healthcare and pharmaceutical innovation.
About Harvest Integrated Research Organization (HiRO)
Harvest Integrated Research Organization (HiRO) is a globally
oriented, innovative clinical research organization (CRO). With
global operations and integrated capabilities, HiRO provides a
full range of cross-border solutions and services to its clients,
including early pre-clinical strategic planning, clinical trial
design, regulatory affairs, pharmacovigilance, statistics, data
management, end-to-end project management, and clinical and medical
monitoring services.
As an emerging global CRO, HiRO strives to become a
market-leading, integrated global clinical research organization
that works collaboratively with biotech and pharmaceutical
companies to bring new products from the laboratory to the market,
providing more effective solutions for patients worldwide. For more
information on HiRO, please visit www.harvestiro.com.
About DeltaMed Solutions
DeltaMed Solutions is a global life sciences CRO. The company
excels in building strategic partnerships with pharmaceutical
companies, biotechnology firms, and CROs. By fostering these
collaborations, DeltaMed Solutions remains at the forefront of
innovation, driving advancements in clinical research and drug
development.
With a focus on flexibility, DeltaMed Solutions offers a
range of service models tailored to meet diverse needs, all backed
by a team of experienced professionals. Their commitment to
excellence ensures the delivery of exceptional quality products,
including CSRs, regulatory submissions, and publications. DeltaMed
Solutions leverages their extensive expertise and experience to
accelerate the market entry of innovative therapies, resulting in
significant reductions in time and cost. For more information on
DeltaMed Solutions, please visit www.deltamedsolutions.com.
For media inquiries, please contact:
info@harvestiro.com
View original
content:https://www.prnewswire.com/news-releases/hiro-acquires-cro-deltamed-solutions-continues-to-expand-cross-border-operations-in-the-us-302187569.html
SOURCE Harvest Integrated Research Organization (HiRO)